GAC Motor, one of China's leading automobile manufacturers, released its first 7-seat SUV, the GS8, at Hangzhou International Expo Center, the main venue of the G20 summit on Oct. 26.
A c-level high-end SUV self-developed by GAC Motor, the GS8 meets the North American SUV roof anti-force standard and redefines Chinese high-end SUV market. It integrates the GAC production system, global R&D network and global supply chain system and has formed the core competitive advantage of sustainable development, leading Chinese brands with innovative paces.
An important step in GAC Motor's strategic plan to fully enter high-end market, the GS8 is a c-level high-end product based on the creative cross-platform modular architecture, a platform focusing on technological innovation to guarantee quality consistency, lowers production and manufacturing cost, accelerates development speed, and expands technical advantages among competitors.
To view the multimedia release go to:
http://www.multivu.com/players/English/7977551-gac-motor-gs8-high-end-suv/
The first all-new 2017 Subaru Impreza rolled off the assembly line at Subaru of Indiana Automotive, Inc. (SIA), officially launching the first-ever American-built Impreza from the automaker. The Impreza had historically been produced only in Japan. The start of Impreza production marks the culmination of more than three years of preparation and highlights the consistent growth in Subaru demand in the United States (U.S.). The positive economic impact of that growth is clear in the investment Subaru made to increase SIA’s production capacity and prepare for Impreza production. SIA invested $1.3 billion over the past four years, and hired an additional 1,400 associates in the past year.
“In a time when some manufacturers are moving work out of the United States, we’re proud to be bringing Subaru Impreza production to the heartland of America,” said Tom Easterday, Senior Executive Vice President of SIA. “The move has allowed us to create hundreds of new jobs not only at SIA, but also at our suppliers in Indiana and across the country.”
The all-new 2017 Subaru Impreza is the first vehicle built using the new Subaru Global Platform architecture that is designed to enhance safety, comfort, agility and driving pleasure. Available in sedan and 5-door models, the 2017 Impreza is equipped with new driver assist technology, multimedia features and standard Symmetrical All-Wheel Drive. The new Impreza will be available in base, Premium, Sport and Limited trim lines starting in late 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7673252-subaru-impreza-first-2017-american-made/
Every 23 seconds, someone in the United States is diagnosed with diabetes. It's estimated that one in 11 Americans has the disease—more than 29 million people—and another 86 million have prediabetes and are at risk for developing type 2 diabetes. The numbers alone are staggering, and the people affected by the disease include those who have diabetes and their friends, family, caregivers and communities.
American Diabetes Month®, observed by the American Diabetes Association® (Association) every November, is a time to focus the nation's attention on the many people who are affected by diabetes and to raise the urgency about the need to address diabetes. To help spark a national conversation, the Association is asking people to share their stories about what it truly means to live with diabetes with a new campaign, This Is Diabetes™.
To view the multimedia release go to:
http://www.multivu.com/players/English/7711431-american-diabetes-month-thisisdiabetes/
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
The health of babies in the United States has taken a step backward as the nation’s preterm birth rate worsened for the first time in eight years, the March of Dimes said today. The U.S. earned a “C” grade on the latest March of Dimes Premature Birth Report Card amidst widening differences in prematurity rates across different races and ethnicities.
“The 2016 March of Dimes Report Card demonstrates that there is an unfair burden of premature birth among specific racial and ethnic groups as well as geographic areas,” says Dr. Jennifer L. Howse, president of the March of Dimes. “The March of Dimes strives for a world where every baby has a fair chance, yet we see this is not the reality for many mothers and babies. Babies in this country have different chances of surviving and thriving simply based on the circumstances of their birth.”
The U.S. preterm birth rate went up from 9.57 to 9.63 in 2015, according to final data from the National Center for Health Statistics (NCHS). Across the country, preterm birth rates were nearly 48 percent higher among black women and more than 15 percent higher among American Indian/Alaska Native women compared to white women.
To view the multimedia release go to:
http://www.multivu.com/players/English/7945951-march-of-dimes-premature-birth-report/
Clayton, one of the largest American builders of manufactured and modular homes, utilizes an internal supply chain management system, known as Clayton Supply, that allows the company to lower costs and pass those savings on to home buyers.
Through its network of facilities that both manufacture and distribute building materials, Clayton is able to offer quick inventory turnaround at reduced costs to its own home building facilities, thereby offering homes at affordable prices to families across America.
Clayton Supply facilities are located across the country and include operations that manufacture vinyl, insulated windows, gypsum wallboard, trusses, cabinets, moldings and much more. In addition to manufacturing its own materials, Clayton Supply also purchases building materials in bulk, moving those materials through a network of regional distribution centers that are strategically located to support its own home building facilities.
To view the multimedia release go to:
https://www.multivu.com/players/English/7716457-clayton-supply-affordable-home-prices
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Joshua Melville, son of radical political activist and Attica uprising leader, Sam Melville, works to share personal experience, 25 years of investigative research and documents the government fought to keep hidden. Find out about his endeavors to make his story known at http://igg.me/at/AmericanTimebomb and contact Josh for an interview at MojoMelville@outlook.com Political, memoir
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
Cole Haan, the iconic American lifestyle footwear and accessories brand and retailer, is proud to launch Made in Maine, USA – a limited-edition collection blending quality American craftsmanship with timeless designs.
“Creating a shoe that will last a lifetime is an exceedingly personal, painstakingly accurate process from start to finish and is the very definition of American craftsmanship. This quality has allowed Cole Haan to build a legacy that lives on today,” explains David Maddocks, Chief Marketing Officer and General Manager of Business Development.
To view the multimedia release go to:
http://www.multivu.com/players/English/7923751-cole-haan-made-in-maine-usa/
James Beard Award-winning Chef Shawn McClain dares guests to embrace their deepest desires and liberate their minds with a flurry of food, drinks and friends at Libertine Social, now open inside Mandalay Bay. The convivial gastropub celebrates New American bar food by the beloved chef, a duel-faceted cocktail program pioneered by Modern Mixologist Tony Abou-Ganim, and a compelling mix of social settings that encourage guests to play and have fun.
“Libertine Social is all about the food, the drinks and the party. We want this to be a playground for people to explore familiar dishes and cocktails with edgy and unexpected flavors in an energetic environment that invites them to share those moments with others,” said McClain. “When people come to Las Vegas, they want to have a good time, and experience the best food and drinks out there with their friends who know how to have fun, which is what Libertine Social is all about.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7915751-libertine-social-at-mandalay-bay/
